We’re a laser manufacturer behind the Pulzar Z+, a solid state refractive laser built on more than 20 years of development and US$50 million in investment, with a track record of excellent clinical outcomes and minimal breakdown.

We didn’t set out to build just another laser. We set out to remove the toxic gas, the gas cylinders, and the recurring replacement costs that conventional excimer lasers require. That work led first to the Pulzar Z1, tested and used by surgeons at sites across multiple countries, with clinical results presented by named investigators at the Congress of the ESCRS, including studies covering more than 900 combined patient eyes. The Pulzar Z+ is our next generation laser, built on that same platform and refined further.

We’re currently expanding availability of the Pulzar Z+ internationally, building on the international use already established by the Pulzar Z1 across multiple countries.